BTCC / BTCC Square / Global Cryptocurrency /
Pfizer Cites Tariff Uncertainty as Barrier to U.S. Investment

Pfizer Cites Tariff Uncertainty as Barrier to U.S. Investment

Global Cryptocurrency
Release Time:
2025-04-29 20:24:02
0

Pfizer CEO Albert Bourla highlighted trade policy uncertainties as a significant constraint on domestic investment during the company’s Q1 earnings call. The pharmaceutical giant seeks clarity on potential tariffs for imported drugs before committing to new U.S.-based R&D and manufacturing projects.

"In periods of uncertainty, everybody is controlling their cost," Bourla stated, emphasizing how trade policy volatility forces corporate caution. The Trump administration’s proposed tariffs aim to reshore pharmaceutical production, but industry leaders demand predictable policy frameworks to justify capital expenditures.

Articles on this site are sourced from public networks or curated by AI for informational purposes only and do not represent BTCC’s views. Original rights belong to the respective authors. For copyright concerns, please contact [email protected]. BTCC assumes no liability for the accuracy, timeliness, or completeness of this information, and disclaims all liability arising from reliance on such content. This content is for reference only and should not be taken as investment, legal, or commercial advice.

|Square

Get the BTCC app to start your crypto journey

Get started today Scan to join our 100M+ users